GRAIL/ILLUMINA SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/17/23
GRAIL/ILLUMINA INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/14/23
INVESTOR ACTION NOTICE FOR LONG-TERM SHAREHOLDERS: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/13/23
Illumina receives record US$476M fine from EU for closing Grail deal without approvalProactive Investors • 07/12/23
Illumina Fined $476 Million For Acquiring Cancer Test Maker Grail Without EU ApprovalForbes • 07/12/23
Illumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discoveryPRNewsWire • 07/11/23
Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?The Motley Fool • 06/20/23
Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to blockCNBC • 06/13/23